In the BioHarmony Drug Report Database

"Preview" Icon

Capreomycin

Capastat Sulfate (capreomycin) is a protein pharmaceutical. Capreomycin was first approved as Capastat Sulfate on 1982-01-01. It is used to treat mycobacterium infections and tuberculosis in the USA.

 

Trade Name

 

Capastat Sulfate
 

Common Name

 

capreomycin
 

ChEMBL ID

 

CHEMBL2221250
 

Indication

 

mycobacterium infections, tuberculosis
 

Drug Class

 

Antibiotics (Streptomyces strains)

Image (chem structure or protein)

Capreomycin structure rendering